PetVivo Holdings, Inc. (PETV)
USD 0.61
(-3.48%)
USD 0.61
(-3.48%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 3.11 Million USD | 27.73% |
| 2023 | 2.43 Million USD | -67.16% |
| 2022 | 7.42 Million USD | 789.24% |
| 2021 | 835.24 Thousand USD | 59.85% |
| 2020 | 522.51 Thousand USD | -24.4% |
| 2019 | 691.14 Thousand USD | -55.92% |
| 2018 | 1.56 Million USD | -17.35% |
| 2017 | 1.89 Million USD | -88.63% |
| 2016 | 16.68 Million USD | 2087.74% |
| 2015 | 762.86 Thousand USD | 330.17% |
| 2014 | 177.33 Thousand USD | 146.47% |
| 2013 | 71.95 Thousand USD | 5221.89% |
| 2012 | 1352.00 USD | -63.84% |
| 2011 | 3739.00 USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 4.06 Million USD | 31.06% |
| 2024 Q3 | 3.62 Million USD | -10.63% |
| 2024 Q4 | 3.11 Million USD | -14.18% |
| 2024 FY | 3.11 Million USD | 27.73% |
| 2024 Q1 | 3.09 Million USD | 27.07% |
| 2023 Q1 | 5.72 Million USD | -22.94% |
| 2023 Q2 | 4.05 Million USD | -29.23% |
| 2023 Q4 | 2.43 Million USD | -5.04% |
| 2023 FY | 2.43 Million USD | -67.16% |
| 2023 Q3 | 2.56 Million USD | -36.6% |
| 2022 Q4 | 7.42 Million USD | -12.58% |
| 2022 FY | 7.42 Million USD | 789.24% |
| 2022 Q2 | 9.91 Million USD | 949.32% |
| 2022 Q1 | 944.81 Thousand USD | 13.12% |
| 2022 Q3 | 8.49 Million USD | -14.3% |
| 2021 Q2 | 726.14 Thousand USD | 25.42% |
| 2021 Q3 | 899.04 Thousand USD | 23.81% |
| 2021 FY | 835.24 Thousand USD | 59.85% |
| 2021 Q1 | 578.96 Thousand USD | 10.8% |
| 2021 Q4 | 835.24 Thousand USD | -7.1% |
| 2020 Q4 | 522.51 Thousand USD | -20.79% |
| 2020 Q1 | 738.3 Thousand USD | 6.82% |
| 2020 Q2 | 648.12 Thousand USD | -12.21% |
| 2020 Q3 | 659.63 Thousand USD | 1.78% |
| 2020 FY | 522.51 Thousand USD | -24.4% |
| 2019 Q4 | 691.14 Thousand USD | -41.7% |
| 2019 Q3 | 1.18 Million USD | -0.74% |
| 2019 Q2 | 1.19 Million USD | -10.91% |
| 2019 Q1 | 1.34 Million USD | -14.49% |
| 2019 FY | 691.14 Thousand USD | -55.92% |
| 2018 FY | 1.56 Million USD | -17.35% |
| 2018 Q4 | 1.56 Million USD | -21.47% |
| 2018 Q3 | 1.99 Million USD | 13.35% |
| 2018 Q2 | 1.76 Million USD | 1.89% |
| 2018 Q1 | 1.72 Million USD | -8.87% |
| 2017 FY | 1.89 Million USD | -88.63% |
| 2017 Q1 | 16.49 Million USD | -1.17% |
| 2017 Q2 | 2.19 Million USD | -86.67% |
| 2017 Q3 | 2.03 Million USD | -7.28% |
| 2017 Q4 | 1.89 Million USD | -6.92% |
| 2016 Q1 | 18.54 Million USD | 2330.75% |
| 2016 Q3 | 17.9 Million USD | 1.55% |
| 2016 Q2 | 17.63 Million USD | -4.92% |
| 2016 Q4 | 16.68 Million USD | -6.79% |
| 2016 FY | 16.68 Million USD | 2087.74% |
| 2015 Q2 | 135.28 Thousand USD | 3.06% |
| 2015 Q1 | 131.26 Thousand USD | -25.98% |
| 2015 FY | 762.86 Thousand USD | 330.17% |
| 2015 Q4 | 762.86 Thousand USD | 137.56% |
| 2015 Q3 | 321.12 Thousand USD | 137.37% |
| 2014 FY | 177.33 Thousand USD | 146.47% |
| 2014 Q3 | 22.49 Thousand USD | 722.03% |
| 2014 Q2 | 2737.00 USD | 61.19% |
| 2014 Q1 | 1698.00 USD | -97.64% |
| 2014 Q4 | 177.33 Thousand USD | 688.2% |
| 2013 FY | 71.95 Thousand USD | 5221.89% |
| 2013 Q1 | 1601.00 USD | 18.42% |
| 2013 Q3 | 54.99 Thousand USD | 629.71% |
| 2013 Q4 | 71.95 Thousand USD | 30.83% |
| 2013 Q2 | 7537.00 USD | 370.77% |
| 2012 FY | 1352.00 USD | -63.84% |
| 2012 Q2 | 2264.00 USD | 0.0% |
| 2012 Q4 | 1352.00 USD | -33.89% |
| 2012 Q3 | 2045.00 USD | -9.67% |
| 2011 Q4 | 3739.00 USD | 0.0% |
| 2011 FY | 3739.00 USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 90.068% |
| BrainsWay Ltd. | 62.97 Million USD | 95.053% |
| Cerus Corporation | 197.74 Million USD | 98.425% |
| Envoy Medical, Inc. | 7.64 Million USD | 59.224% |
| electroCore, Inc. | 16.38 Million USD | 80.989% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | 59.5% |
| IceCure Medical Ltd | 16.41 Million USD | 81.016% |
| Inogen, Inc. | 326.19 Million USD | 99.045% |
| OrthoPediatrics Corp. | 449.58 Million USD | 99.307% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 88.576% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 81.21% |
| MaxCyte, Inc. | 268.27 Million USD | 98.839% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | 61.527% |
| Nexalin Technology, Inc. | 3.63 Million USD | 14.226% |
| Orthofix Medical Inc. | 925.31 Million USD | 99.663% |
| PAVmed Inc | 33.11 Million USD | 90.594% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 97.828% |
| RxSight, Inc. | 182.55 Million USD | 98.293% |
| Sight Sciences, Inc. | 166.65 Million USD | 98.131% |
| SI-BONE, Inc. | 230.42 Million USD | 98.648% |
| TELA Bio, Inc. | 78.04 Million USD | 96.009% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 98.763% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | 70.967% |
| Acutus Medical, Inc. | 53.96 Million USD | 94.227% |
| Talis Biomedical Corporation | 98.34 Million USD | 96.832% |
| Spectral AI, Inc. | 10.69 Million USD | 70.864% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 98.575% |
| CVRx, Inc. | 115.22 Million USD | 97.296% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 94.689% |
| Bioventus Inc. | 810.91 Million USD | 99.616% |
| Venus Concept Inc. | 93.65 Million USD | 96.674% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 87.89% |
| LivaNova PLC | 2.42 Billion USD | 99.872% |
| 908 Devices Inc. | 202.98 Million USD | 98.465% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 99.613% |
| Nemaura Medical Inc. | 14.56 Million USD | 78.609% |
| NeuroPace, Inc. | 107.65 Million USD | 97.106% |
| LENSAR, Inc. | 69.58 Million USD | 95.523% |
| Apyx Medical Corporation | 79.24 Million USD | 96.069% |
| Cutera, Inc. | 346.29 Million USD | 99.1% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 92.586% |
| BioSig Technologies, Inc. | 1.79 Million USD | -73.262% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 98.849% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 92.698% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.918% |
| Axonics, Inc. | 719.92 Million USD | 99.567% |
| Outset Medical, Inc. | 313.8 Million USD | 99.007% |
| IRIDEX Corporation | 34.43 Million USD | 90.953% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 99.23% |
| IRadimed Corporation | 92.15 Million USD | 96.62% |
| Tivic Health Systems, Inc. | 5.25 Million USD | 40.707% |
| INVO Bioscience, Inc. | 20.88 Million USD | 85.086% |
| Telesis Bio, Inc. | 70.41 Million USD | 95.576% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 97.978% |
| Varex Imaging Corporation | 1.24 Billion USD | 99.751% |
| Quipt Home Medical Corp. | 247.4 Million USD | 98.741% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 66.539% |
| Pulmonx Corporation | 178.95 Million USD | 98.259% |
| Dynatronics Corporation | 25.94 Million USD | 87.991% |
| Modular Medical, Inc. | 13.8 Million USD | 77.437% |
| ReShape Lifesciences Inc. | 10.72 Million USD | 70.959% |
| Semler Scientific, Inc. | 78.06 Million USD | 96.009% |
| InMode Ltd. | 863.28 Million USD | 99.639% |
| Bruker Corporation | 4.24 Billion USD | 99.927% |
| Cytosorbents Corporation | 53.26 Million USD | 94.151% |
| DexCom, Inc. | 6.26 Billion USD | 99.95% |
| Align Technology, Inc. | 6.08 Billion USD | 99.949% |
| Viveve Medical, Inc. | 25.91 Million USD | 87.978% |
| ZimVie Inc. | 1.2 Billion USD | 99.742% |
| Movano Inc. | 9.42 Million USD | 66.933% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 99.374% |
| Nexalin Technology, Inc. | 3.63 Million USD | 14.226% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 94.689% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 99.673% |
| Profound Medical Corp. | 43.68 Million USD | 92.869% |
| Insulet Corporation | 2.58 Billion USD | 99.88% |
| enVVeno Medical Corporation | 48.63 Million USD | 93.595% |
| Surmodics, Inc. | 185.73 Million USD | 98.323% |
| iCAD, Inc. | 41.41 Million USD | 92.479% |
| Nuwellis, Inc. | 9.77 Million USD | 68.114% |
| Biotricity, Inc. | 5.94 Million USD | 47.578% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 99.281% |
| Aethlon Medical, Inc. | 8.24 Million USD | 62.221% |
| InspireMD, Inc. | 47.64 Million USD | 93.461% |
| PAVmed Inc. | 33.11 Million USD | 90.594% |
| BIOLASE, Inc. | 35.1 Million USD | 91.125% |
| Beyond Air, Inc. | 56.96 Million USD | 94.531% |
| FONAR Corporation | 214.24 Million USD | 98.546% |
| AxoGen, Inc. | 196.82 Million USD | 98.417% |
| Vivani Medical, Inc. | 45.79 Million USD | 93.198% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 98.893% |
| Inari Medical, Inc. | 674.23 Million USD | 99.538% |
| UFP Technologies, Inc. | 404.13 Million USD | 99.229% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 86.686% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | 67.219% |
| Tenon Medical, Inc. | 6.34 Million USD | 50.902% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | 66.884% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 96.994% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.933% |
| Sintx Technologies, Inc. | 15.36 Million USD | 79.725% |
| NanoVibronix, Inc. | 6.67 Million USD | 53.323% |
| Quanterix Corporation | 425.01 Million USD | 99.267% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 66.539% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 94.202% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.822% |
| TransMedics Group, Inc. | 706.04 Million USD | 99.559% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 95.07% |
| NeuroMetrix, Inc. | 21.42 Million USD | 85.459% |
| Hyperfine, Inc. | 94.19 Million USD | 96.693% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 98.84% |
| Biomerica, Inc. | 9.25 Million USD | 66.336% |
| Bone Biologics Corporation | 3.73 Million USD | 16.655% |
| AVITA Medical, Inc. | 144.33 Million USD | 97.842% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | 36.012% |
| Silk Road Medical, Inc | 265.3 Million USD | 98.826% |